Mesenchymal subtype negatively associates with the presence of immune infiltrates within a triple negative breast cancer classifier

被引:0
|
作者
Grigoriadis, A.
Quist, J.
Mirza, H.
Cheang, M. C.
Ring, B. Z.
Hout, D. R.
Bailey, D. B.
Seitz, R. S.
Tutt, A. N.
机构
[1] Kings Coll London, Canc Bioinformat, London, England
[2] Kings Coll London, Breast Canc Now, London, England
[3] Inst Canc Res, London, England
[4] Insight Genet Inc, Nashville, TN USA
[5] Inst Canc Res, Breast Canc Now, London, England
关键词
D O I
10.1158/1538-7445.SABCS16-P1-07-03
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-07-03
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype
    Nistico, Nancy
    Aloisio, Annamaria
    Lupia, Antonio
    Zimbo, Anna Maria
    Mimmi, Selena
    Maisano, Domenico
    Russo, Rossella
    Marino, Fabiola
    Scalise, Mariangela
    Chiarella, Emanuela
    Mancuso, Teresa
    Fiume, Giuseppe
    Omodei, Daniela
    Zannetti, Antonella
    Salvatore, Giuliana
    Quinto, Ileana
    Iaccino, Enrico
    CELLS, 2023, 12 (07)
  • [32] Triple negative apocrine carcinomas as a distinct subtype of triple negative breast cancer: A case-control study
    Meattini, Icro
    Pezzulla, Donato
    Carta, Giulio Alberto
    Becherini, Carlotta
    Perna, Marco
    Grassi, Roberta
    Garlatti, Pietro
    Desideri, Isacco
    Scotti, Vieri
    Bernini, Marco
    Sanchez, Luis Jose
    Orzalesi, Lorenzo
    Nori, Jacopo
    Bianchi, Simonetta
    Livi, Lorenzo
    CANCER RESEARCH, 2018, 78 (04)
  • [33] Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study
    Meattini, Icro
    Pezzulla, Donato
    Saieva, Calogero
    Bernini, Marco
    Orzalesi, Lorenzo
    Sanchez, Luis Jose
    Desideri, Isacco
    Francolini, Giulio
    Bonomo, Pierluigi
    Greto, Daniela
    Loi, Mauro
    Mangoni, Monica
    Bruni, Alessio
    Nori, Jacopo
    Vezzosi, Vania
    Bianchi, Simonetta
    Livi, Lorenzo
    CLINICAL BREAST CANCER, 2018, 18 (05) : E773 - E780
  • [34] Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer
    Diaz-Martin, Juan
    Angeles Lopez-Garcia, Maria
    Romero-Perez, Laura
    Reina Atienza-Amores, Maria
    Luisa Pecero, Maria
    Angeles Castilla, Maria
    Biscuola, Michele
    Santon, Almudena
    Palacios, Jose
    ENDOCRINE-RELATED CANCER, 2015, 22 (03) : 443 - 454
  • [35] The role of the immune system in triple-negative breast cancer
    Cvetka, Grasic Kuhar
    ONKOLOGIJA, 2020, 24 (01) : 32 - 38
  • [36] Immune checkpoints A therapeutic target in triple negative breast cancer
    Chawla, Akhil
    Philips, Anne V.
    Alatrash, Gheath
    Mittendorf, Elizabeth
    ONCOIMMUNOLOGY, 2014, 3 (04)
  • [37] The role of immune checkpoint inhibition in triple negative breast cancer
    Tarekegn, Kidist
    Keskinkilic, Merve
    Kristoff, Tyler J.
    Evans, Sean T.
    Kalinsky, Kevin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (10) : 1095 - 1106
  • [38] Immune Checkpoint Proteins Evaluation in Triple Negative Breast Cancer
    Elsheikh, S.
    Amoah-Duodu, A.
    Nolan, C.
    Green, A.
    Aleskandarany, M.
    Rakha, E.
    JOURNAL OF PATHOLOGY, 2018, 246 : S22 - S22
  • [39] Evaluation of triple negative breast cancer with heterogeneous immune infiltration
    Quintana, Angela
    Arenas, Enrique Javier
    Bernado, Cristina
    Navarro, Jose Fernandez
    Gonzalez, Jonatan
    Esteve-Codina, Anna
    Moline, Teresa
    Marti, Merce
    Curigliano, Giuseppe
    Schmid, Peter
    Peg, Vicente
    Arribas, Joaquin
    Cortes, Javier
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] The immune microenvironment in young patients with triple negative breast cancer
    McKenzie, H.
    Martland, G.
    Eccles, D.
    Copson, E.
    Thomas, G.
    VIRCHOWS ARCHIV, 2019, 475 : S15 - S16